CEOs of Novo Nordisk Discuss Rising Prices and Drug Shortages for Ozempic and Wegovy

The blockbuster drugs Ozempic and Wegoby have made waves around the world and changed the way people lose weight. In an exclusive interview, NBC News’ Megan Fitzgerald speaks with Lars Fluagaard Jorgensen, the CEO of Novo Nordisk who orchestrated it all, to ask about high prices, drug shortages and the long-term effects.
August 25, 2024